Remission of positive symptomatology of a schizophrenic psychosis after withdrawing lamotrigine: A case report

European Psychiatry

Volumn 19, Issue 1, 2004, Pages 59-61

  Stuve, W ^a   Wessels, A ^a   Timmerman, L ^a  

^a Adhesie Foundation for Mental Health Care Midden Overijssel   (Netherlands)

Author keywords

Glutamate; Lamotrigine; Schizophrenia

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; HALOPERIDOL; LAMOTRIGINE; OLANZAPINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; DRUG WITHDRAWAL; HUMAN; LABORATORY TEST; MALE; PARANOID PSYCHOSIS; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 1142273200     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2003.07.006     Document Type: Article

References (13)

1. Besag F.M.C. Lamotrigine in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research. 42:1998;50-56.
2. Bleich S., Bleich K., Wiltfang J., Maler M., Kornhuber J. Glutaminerge Neurotransmission bei Schizofrenien. Fortschritter der Neurologischer Psychiatrie. 2:2001;S56-S61. 69 Sonderheft.
3. Brodie M.J. Lamotrigine. The Lancet. 339:1992;1397-1400.
4. Cockerel O.C., Moriarty J., Trimble M., Jusemir J.W.A.S., Shorvon S.D. Acute psychological disorders in patients with epilepsy: a nation wide study. Epilepsy Research. 25:1996;119-131.
5. De Leon O.A., Furmaga K.M. Effect of lamotrigine treatment in epileptic psychosis. Journal of Clinical Psychopharmacology. 19:(2):1999;186-187.
6. Erfurth A., Walden J., Grunze H. Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology. 38:1999;204-205.
7. Goff D.C., Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry. 58:2001;1367-1377.
8. Kotler M., Matar M.A. Lamotrigine in the treatment of resistant bipolar disorder. Clinical Neuropharmacology. 21:1998;65-67.
9. Hertzberg M.A., Butterfield M.I., Feldman M.E., Beckham J.C., Sutherland S.M., Connor K.M., et al. A Preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biological Psychiatry. 45:1999;1226-1229.
10. Martin M., Munos-Blanco J.L., Lopez-Ariztegui N. Acute psychosis induced by lamotrigine. Epilepsia. 36:(Suppl 3):1995;118.
11. Mechri A., Saoud M., Khiari G., d'Amato T., Dalery J., Gaha L., et al. Hypothèse glutaminergique de la schizophrénie: apports de recherches cliniques sur la ketamine. L'Encéphale. 28:2001;53-59.
12. Polselli G.M., Pennisi E.M., Figà Talamanca L., Roberti R., Fiume Garelli F., Bandinelli P.L., et al. Psychotic disorder after lamotrigine. Italian Journal of Neurological Science. 19:1998;124-125.
13. Tascedda F., Blom J.M.C., Brunello N., Zolin K., Gennarelli M., Colzi A., et al. Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. Biological Psychiatry. 50:2001;117-122.